| ²é¿´: 1251 | »Ø¸´: 5 | ||
ת½Ç´¦µÄÍɱäľ³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
±à¼»Ø¸åÁË£¬Çó³æÓÑÃǰïÎÒ¿´¿´½ÓÊյĸÅÂʸßÂ𣿠ÒÑÓÐ1È˲ÎÓë
|
|
The reviewer(s) would like to see some revisions made to your manuscript before the next re-evaluation step. Therefore, I invite you to respond to the reviewer(s)' comments and revise your manuscript. This second evaluation step does not necessary implicate that your manuscript will be finally accepted. IMPORTANT: Your original files are available to you when you upload your revised manuscript. Please delete any redundant files before completing the submission. Because we are trying to facilitate timely publication of manuscripts submitted to Drug Development and Industrial Pharmacy, your revised manuscript should be uploaded as soon as possible. If it is not possible for you to submit your revision in a reasonable amount of time, we may have to consider your paper as a new submission. Reviewer: 1 Comments to the Author This article is mainly to investigate the spectral patterns in the Nifedipine/ Soluplus/ Kollidon solid dispersions (SD).The evaluation of the solid dispersions was also done. The authors have done many works in order to make the experiment persuasive and creditable. Some questions and advice were given about this article¡£ 1. The X-ray diffraction method should be employed in comparison to FT-IR. 2.The aging of solid dispersions is a common problem¡£The application of different preparation methods was not enough to deal with the aging problem¡£ The formula modification attempts were absent in this article¡£ 3.The publication period of most references was a little old and should be updated. Peer Reviewer: 2 Comments to the Author 1. Please modify the English expressions in details of this paper carefully. 2. Are the samples prepared for SEM before or after milling? If they are milled samples, the SEM spectrum cannot tell the original morphology. And SEM may not be a strong technic to distinguish the polymorphs of the materials (amorphous or crystalline). 3. Could the author provide a Tg of the formulation from the DSC, which could be a better proof to prove the formulations are amorphous? 4. ¡°The interaction strength between the drugs and the polymers can determine the degree that the crystal state change into the amorphous state.¡± Is there any paper support this theory? 5. If the author could show the SEM under the same enlargement factor , that would be easy to compare. 6. Could the author explain the Figure 7 more in details? 7. Is Figure 8 drawn based on the FT-IR results? Could the author please tell what FTIR in corresponded with which interactions? 8. Is the intensity of the FTIR related to the amount author used to make the KBr pellet? How to control this variable? 9. Is there any possible that there also exists interaction between two polymers in formulation? And please explain why the author used both two polymers in one formulation? Çó¸÷λÈÈÐijæÓѰïÎÒ¿´¿´½ÓÊյĸÅÂʸßÂð£¿Õâ¸öÐÞ¸ÄÒâ¼ûËã¶àÂ𣿠|
» ²ÂÄãϲ»¶
315Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ£¬085600£¬344·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸ ½ÄÏ´óѧ 085602 »¯¹¤×¨Ë¶ 338·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
»¯Ñ§0703-Ò»Ö¾Ô¸211-338·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö
ÒѾÓÐ8È˻ظ´
085602µ÷¼Á ³õÊÔ×Ü·Ö335
ÒѾÓÐ9È˻ظ´
336²ÄÁÏÓ뻯¹¤085600Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ6È˻ظ´
071000ÉúÎïѧµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÉúƽµÚһƪSCI£¬Àú¾²¨ÕÛºóÖÕÓÚÊÕµ½ÐÞ¸ÄÒâ¼û£¬´ó¼Ò¿´¿´Óжà´óµÄ·¢±í¸ÅÂÊ£¡
ÒѾÓÐ41È˻ظ´
×ÉѯÎÄÕ½ÓÊÕºó±à¼µÄÐÅ£¬Çó°ï棡
ÒѾÓÐ3È˻ظ´
±à¼¸øµÄ»Ø¸´ÊÇÕâÑùµÄ£¬ÕâÑù×îºó½ÓÊܵļ¸ÂÊ´óÂð£¿
ÒѾÓÐ5È˻ظ´
ÂÛÎÄÍËÐÞÊÇɶÒâË¼ÄØ£¬½ÓÊܵĸÅÂÊ´óÂð
ÒѾÓÐ12È˻ظ´
ÂÛÎÄ´óÐÞ¸å½øÈëAwaiting decision״̬£¬ÇëÎʽÓÊܸÅÂʶà´ó£¿
ÒѾÓÐ13È˻ظ´
¡¶²â¿Ø¼¼Êõ¡·ÍËÐÞ£¬Óжà´óµÄ»úÂʱ»½ÓÊܰ¡£¿
ÒѾÓÐ13È˻ظ´
ÇëÎÊͶÎÄÕµÄʱºò°´ÕÕÆÚ¿¯Ä£°æ»áÔö¼Ó½ÓÊÕ¸ÅÂÊÂð£¿
ÒѾÓÐ5È˻ظ´
һƪÎÄÕ±»JACS¾ÜÁË£¬ÏëÖØÍ¶£¬ÇëÎʾßÌåÔõôÁªÏµ¸±Ö÷±à°¡£¿±»½ÓÊܵļ¸ÂÊÓжà´ó°¡£¿
ÒѾÓÐ30È˻ظ´
´óÐÞºó rereviewerÉó¸åʱ¼äÓë½ÓÊյĸÅÂÊÓйØÏµÃ´
ÒѾÓÐ5È˻ظ´
Ì×´ÅÖ®ºóÍâµ¼»ØÐÅÁË£¬ÇëÎʸ÷λÕâÖÖÇé¿ö½ÓÊյĸÅÂÊÓжà´ó£¿
ÒѾÓÐ13È˻ظ´
ÖйúÎïÀí¿ì±¨¡°ÍËÐÞ¡±×´Ì¬½ÓÊܵĸÅÂÊÓжà´ó
ÒѾÓÐ11È˻ظ´
Major revisions ½ÓÊյļ¸ÂÊÊǶàÉÙ°¡ ´ó²» ÓоÀúµÄ̸̸¡£¡£¡£
ÒѾÓÐ18È˻ظ´
´ó¼Ò°ïÎÒ¿´¿´Éó¸åÈ˵ÄÒâ¼ûÊÇ´óÐÞ»¹ÊÇСÐÞ£¬½ÓÊÕ¸ÅÂʶà´ó
ÒѾÓÐ9È˻ظ´
moderate revise Ö®ºó2Ìì±ä³ÉDecision in Process½ÓÊյļ¸ÂÊ´óÂð
ÒѾÓÐ74È˻ظ´
¡¾ÇóÖú¡¿Ó¢¹úµÄ²©Ê¿ÉêÇ룬µ¼Ê¦Í¬Òâ½ÓÊÜÁË£¬Í¨¹ýѧУµÄÉó²éµÄ¸ÅÂÊÓжà´ó£¿
ÒѾÓÐ21È˻ظ´
±»Í˸壬ÔÙͶ´ËÔÓÖ¾½ÓÊܵļ¸ÂÊ´óÂð£¿
ÒѾÓÐ15È˻ظ´
journal of power sources ·µ»Ørevision½ÓÊܵļ¸ÂÊÓжà´ó£¿
ÒѾÓÐ9È˻ظ´

zhangyo_hust
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 939.1
- É¢½ð: 46
- ºì»¨: 2
- Ìû×Ó: 105
- ÔÚÏß: 180.5Сʱ
- ³æºÅ: 2489634
- ×¢²á: 2013-05-31
- רҵ: º£Ñ󹤳Ì
2Â¥2014-03-24 16:02:56
ת½Ç´¦µÄÍɱä
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2585.1
- Ìû×Ó: 25
- ÔÚÏß: 21.6Сʱ
- ³æºÅ: 1215703
- ×¢²á: 2011-02-28
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÒ©Îï

3Â¥2014-03-24 16:06:59
zhangyo_hust
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 939.1
- É¢½ð: 46
- ºì»¨: 2
- Ìû×Ó: 105
- ÔÚÏß: 180.5Сʱ
- ³æºÅ: 2489634
- ×¢²á: 2013-05-31
- רҵ: º£Ñ󹤳Ì
4Â¥2014-03-24 16:12:10
ת½Ç´¦µÄÍɱä
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2585.1
- Ìû×Ó: 25
- ÔÚÏß: 21.6Сʱ
- ³æºÅ: 1215703
- ×¢²á: 2011-02-28
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÒ©Îï

5Â¥2014-03-24 16:21:44
zhangyo_hust
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 939.1
- É¢½ð: 46
- ºì»¨: 2
- Ìû×Ó: 105
- ÔÚÏß: 180.5Сʱ
- ³æºÅ: 2489634
- ×¢²á: 2013-05-31
- רҵ: º£Ñ󹤳Ì
6Â¥2014-03-24 16:45:37














»Ø¸´´ËÂ¥